In the UK, sales of Genito Urinary System and Sex Hormones as a percentage of total sales are predicted to decline gradually from 2024 through 2028. Starting in 2024 with 3%, projections estimate a decrease to 2.6% by 2028. This downward trend indicates a constant year-on-year decrease of 0.1 percentage points, suggesting a period of contraction in this category. Reviewing the past data will highlight if this is a reversal from previous patterns.
Future trends to watch include:
- Potential shifts in healthcare policies affecting drug pricing or availability.
- Emerging medical technologies offering alternative treatments.
- Changes in demographic health needs influencing demand.
- Pharmaceutical innovations entering the market.
- Social factors affecting consumer use and preference.
